Results 221 to 230 of about 322,522 (351)

Legal Challenges In The Implementation Of Change In The Authority To Issue Certificates of Inheritance After  Ministry of Agrarian Affairs and Spatial Planning Regulation Number 16 Of 2021

Bunga Jasmine Puji Hapsari, Shofiy Zulfah   +1 more
openalex   +2 more sources

Enhancements for distributed certificate authority approaches for mobile wireless ad hoc networks.

, 2003
Brian Van Leeuwen, John Michalski, W Anderson   +2 more
openalex   +2 more sources

Systemic T Cell Receptor Profiling Reveals Adaptive Immune Activation and Potential Immune Signatures of Diagnosis and Brain Atrophy in Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin, Sang Bin Hong, Yong Woo Shin, Inpyeong Hwang, Jaeseong Oh, Jihyeon Choi, Narae Kim, Jangsup Moon, Keun‐Hwa Jung, Kyung‐Il Park, Ki‐Young Jung, Kon Chu, Sang Kun Lee   +12 more
wiley   +1 more source

Chronic kidney disease progression, long-term nursing care burden and habitual physical activity: an observational study in Japan. [PDF]

BMJ Public Health
Ohashi Y, Sugishita A, Kurokawa H, Hori Y, Kato S, Mizuno M, Nakatochi M.   +6 more
europepmc   +1 more source

The U.S. Food Safety Modernization Act: Implications in Transnational Governance of Food Safety, Food System Sustainability, and the Tension with Free Trade [PDF]

, 2015
Fortin, Neal
core   +1 more source

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

Disability certification for mental illness in India: 'A bird in the hand is worth two in the bush'. [PDF]

Indian J Psychiatry
Nishanth KN, Sivakumar T.
europepmc   +1 more source

Civil Society Actors as Legal Authorities: The Constitution of Certification Bodies

, 2012
Jaye Ellis
openalex   +1 more source

SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas, Pablo Iruzubieta, Alberto Damborenea, Laura Pérez‐Fernández, Inmaculada Azorín, Juan Carlos Jiménez García, Ana Töpf, Pilar Martí, Lorena Fores‐Toribio, María Manterola, Rosana Blanco‐Mañez, Oihane Pikatza‐Menoio, Sonia Alonso‐Martín, Volker Straub, Aitziber L. Cortajarena, Adolfo López de Munain, David De Sancho, Lorea Blázquez, Juan J. Vilchez   +18 more
wiley   +1 more source

Blockchain-based trusted traceability and sustainability certification of leather products. [PDF]

PLoS One
Islayem R, Hasan HR, Musamih A, Salah K, Jayaraman R.   +4 more
europepmc   +1 more source